Skip to main content
Clinical Trials/NCT01567072
NCT01567072
Completed
Phase 3

Non Steroidal Antiinflammatory Drugs Influence on Heal of Distal Radius Fracture

Marius Aliuskevicius1 site in 1 country192 target enrollmentApril 2012

Overview

Phase
Phase 3
Intervention
Ibuprofen
Conditions
Forearm Fracture
Sponsor
Marius Aliuskevicius
Enrollment
192
Locations
1
Primary Endpoint
Evaluation of changes of fractures position by X rays investigation
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

It is believed, that Non Steroidal Antiinflammatory Drug (NSAID) drugs slows bone healing, but the knowledge is based only on animal studies, and the results are automatically raised for the people.

Many patients with bone fracture must therefore avoid the formerly so popular and good painkillers, although no clinical trial evidence is, that this medicine is really harmful for patients with fractures.

The purpose of this study is to investigate whether these drugs slows bone healing, and what the relationship is between various bone studies - DEXA scanning, biochemical bone marker tests, radiographic controls and tissue examination of newly formed bone under a microscope. How sensitive and specific, each of the above study methods? If they are just as sensitive, the cheapest of them recommended as a routine investigation on suspicion of bone effects. Furthermore, to compare the benefit (pain-relieving effect, influence on rehabilitation) of these drugs and their possible harmful side effects (affected and delayed bone healing).

The expectation is that the study may contribute to increased knowledge about NSAIDs effect do pain management, rehabilitation and the entire treatment process significantly easier and safer, so that patients recover faster and return to usual activities.

Registry
clinicaltrials.gov
Start Date
April 2012
End Date
September 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Marius Aliuskevicius
Responsible Party
Sponsor Investigator
Principal Investigator

Marius Aliuskevicius

Principal Investigator

Aalborg University Hospital

Eligibility Criteria

Inclusion Criteria

  • written acceptance to participate in the study
  • immobilisation or reposition or surgery demanding Colles fracture (which needs to be fixed with external fixation).

Exclusion Criteria

  • age - younger than 50 years or older than 80 years
  • treatment with prednisolon
  • NSAIDs - treatment
  • previous fracture or surgery at the wrist
  • lack of mental and physical capacity to follow studies' instructions
  • lack of informed consent
  • other diseases can affect bone substance (oncology, endocrine diseases)
  • medical contraindications to NSAIDs use
  • smoking, alcohol consumption of more than 14 drinks per week
  • secondary dislocation of fracture also apply as exclusion criterion.

Arms & Interventions

NSAIDs in 3 days

NSAIDs (Ibuprofen) in the first 3 days and placebo in the last 4 days

Intervention: Ibuprofen

Placebo

Only placebo in 7 days

Intervention: Placebo

NSAIDs in 7 days

NSAIDs (Ibuprofen) in 7 days

Intervention: Ibuprofen

Outcomes

Primary Outcomes

Evaluation of changes of fractures position by X rays investigation

Time Frame: 1 week, 2 weeks, 6 weeks

Measurement of possible secondary dislocation

Secondary Outcomes

  • Bone Biochemical markers(1 week, 2 weeks, 5 weeks, 3 months, 1 year)
  • Histomorfometrical evaluation of bone biopsy from callus area(6 weeks)
  • DEXA - scanning(12 weeks)

Study Sites (1)

Loading locations...

Similar Trials